Malady Kyle sold 1,100 Verizon Communications shares at $51.19 each, a transaction representing about 1.0% of the prior holding. After the sale, Kyle owned 105,466 shares, giving investors the stated transaction scale and post-sale ownership position.
Key Highlights
- Malady Kyle’s listed role is EVP and Group CEO-VZ Business at Verizon Communications INC.
- The filing records the transaction under SEC code S.
- Kyle owned 105,466 Verizon Communications shares after the transaction.
Verizon Communications INC (NYSE: VZ) executive Malady Kyle sold 1,100 shares at $51.19 per share on September 15. The transaction was recorded under code S.
Transaction Details Include Code S
The filing records the transaction under code S. The report lists Kyle’s role as EVP and Group CEO-VZ Business. The stated price was $51.19 for each of the 1,100 shares sold. The transaction date was September 15, 2026.
Sale Represented About 1.0% of Prior Holding
Kyle’s reported position after the transaction stood at 105,466 shares. The sale represented about 1.0% of Kyle’s prior shares holding. The percentage uses the prior holding as its stated reference, while the 105,466 figure describes the position after the sale.
FAQs
Q: How many Verizon Communications shares did Malady Kyle sell?
A: Malady Kyle sold 1,100 Verizon Communications shares at $51.19 per share on September 15, 2026. The transaction used code S.
Q: How many Verizon Communications shares did Kyle own after the sale?
A: After the transaction, Kyle owned 105,466 Verizon Communications shares, according to the filing. The 1,100-share sale represented about 1.0% of Kyle’s prior shares holding.
Q: What does transaction code S mean for Verizon Communications shares?
A: The filing uses code S as the SEC transaction code for this reported sale. It records 1,100 Verizon Communications shares sold at $51.19 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.